China SXT Pharmaceuticals, Inc. (SXTC)

China SXT Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	18.1	12.07	17.37	15.52	13.33
Short-Term Investments	0.14	-	-	-	-
Cash & Short-Term Investments	18.24	12.07	17.37	15.52	13.33
Cash Growth	51.09%	-30.50%	11.88%	16.43%	82.97%
Accounts Receivable	1.3	1.31	1.34	3.37	4.51
Other Receivables	0.47	0.03	0.23	0.66	0.65
Receivables	1.9	1.35	1.58	5.53	6.66
Inventory	1.13	0.81	0.58	1.07	1.38
Restricted Cash	0.03	0.01	-	0.05	0.03
Other Current Assets	-	-	-	0.29	1.83
Total Current Assets	21.3	14.23	19.52	22.45	23.23
Property, Plant & Equipment	0.36	0.56	1.27	1.59	1.79
Other Intangible Assets	0.01	0.02	0.03	0.04	0.05
Long-Term Deferred Tax Assets	-	-	-	-	0.32
Other Long-Term Assets	-	8.31	8.74	9.46	9.16
Total Assets	21.66	23.13	29.55	33.55	34.55
Accounts Payable	1.16	1.28	1.38	1.48	1.46
Accrued Expenses	1.78	1.59	1.74	2.01	1.51
Short-Term Debt	0.7	3.32	8.53	10.73	12.15
Current Portion of Long-Term Debt	0.01	0.02	0.01	0.01	0.04
Current Portion of Leases	0.06	0.06	0.06	-	-
Current Income Taxes Payable	1.03	1.05	1.1	1.17	1.16
Current Unearned Revenue	0.06	0.19	0.17	-	-
Other Current Liabilities	1.21	1.39	1.52	1.72	2.26
Total Current Liabilities	6.01	8.9	14.5	17.12	18.58
Long-Term Debt	0.1	0.12	0.12	-	0.01
Long-Term Leases	0.12	0.18	0.25	-	-
Total Liabilities	6.22	9.2	14.86	17.12	18.59
Common Stock	44.53	39.67	0.91	0.16	0.06
Additional Paid-In Capital	-	-	35.59	30.99	25.32
Retained Earnings	-28.02	-24.71	-21.61	-15.69	-9.95
Comprehensive Income & Other	-1.08	-1.03	-0.2	0.96	0.53
Shareholders' Equity	15.44	13.93	14.69	16.42	15.96
Total Liabilities & Equity	21.66	23.13	29.55	33.55	34.55
Total Debt	0.98	3.7	8.96	10.74	12.19
Net Cash (Debt)	17.25	8.38	8.41	4.78	1.14
Net Cash Growth	106.00%	-0.39%	75.82%	319.07%	102.64%
Net Cash Per Share	12.12	77.24	251.95	-	-
Filing Date Shares Outstanding	116.03	0.43	0.07	0.01	-
Total Common Shares Outstanding	13.76	0.28	0.06	0.01	-
Working Capital	15.28	5.33	5.02	5.33	4.65
Book Value Per Share	1.12	50.24	256.97	1617.08	-
Tangible Book Value	15.43	13.91	14.66	16.39	15.92
Tangible Book Value Per Share	1.12	50.17	256.48	1613.27	-
Machinery	1.04	1.19	1.24	1.27	1.19
Construction In Progress	-	-	-	0.36	0.36
Leasehold Improvements	1.56	1.56	1.64	1.78	1.7

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q